Skip to main content

Scientists complete the first successful transplant of lab-grown lungs

For the first time ever, lungs grown in a lab have been successfully transplanted into pigs, allowing them to breathe normally with no medical complications. The breakthrough achievement opens up the possibility of using similarly bioengineered lungs for humans in need of a lung transplant.

“This is the first time someone has transplanted a whole bioengineered organ,” Joan Nichols, associate director of the Galveston National Laboratory at University of Texas Medical Branch, told Digital Trends. “We also demonstrate amazing tissue growth and development of the vascular system. There was no infection, no rejection of tissues, and animals tolerated the bioengineered lung transplant very well.”

To make the lab-grown lungs, the researchers first created a scaffold which came from an unrelated donor pig. They achieved this using a process in which all cells and blood are removed from the organ, leaving just a skeleton. Next, the researchers removed a single lung from a pig as the cell source to produce a bioengineered tissue-matched lung for transfer. This was treated with growth factor-filled hydrogels and nanoparticles to prepare the scaffold for the addition of cells, which came from a single lung taken from each of the “patient” pigs 30 days before the operation. The finished bioengineered lung — featuring cells from the patient — was then transplanted into the pigs.

Six bioengineered lungs were created in total, although only four animals were capable of receiving them due to surgical issues.

“The lungs continued to grow and develop in each animal’s body,” Nichols said. “The growth factors help the cells to survive, and also help us make sure that when we add each type of cell — vascular or blood vessel or lung-specific cell — onto the scaffold that the cells stay where we need them to be.”

Previous work by the team has shown that it is possible to produce a pediatric-sized lung which could be used in human patients. To get to the point of clinical trials, Nichols estimated an additional five to eight years of preclinical testing is needed. Once this is complete, however, the results could be a game-changer in terms of ending organ transplant waiting lists.

A paper describing the work was recently published in the journal Science Translational Medicine.

Editors' Recommendations

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
British doctors successfully completed the world’s first robotic surgery on a human eye
worlds first robotic eye surgery feat

Steady hands are a necessity for all surgeons, but what happens when that necessity exceeds that of a human doctor’s abilities?

The answer appears to lie within robotics, as British surgeons this week “successfully performed the world’s first robotic operation inside the eye, potentially revolutionizing the way such conditions are treated,” the Guardian reported. The surgery, which took place in Oxford’s John Radcliffe Hospital by Professor Robert MacLaren, was performed on a patient who had a membrane growing on the surface of his retina, “which had contracted and pulled it into an uneven shape. The membrane is about a 100th of a millimeter thick and needed to be dissected off the retina without damaging it.”

Read more
A uterus transplant was just completed in the U.S. for the first time
uterus transplant www usnews

Human bodies are becoming the ultimate renewable resource as the medical field continues to march forward into the 21st century. On Thursday, surgeons at the Cleveland Clinic successfully completed the first ever uterus transplant in the United States, giving new hope to women who may have related childbirth issues. The surgery took place over the course of nine hours, and the 26-year-old patient (whose identity has been withheld to protect her privacy) is said to be in stable condition.

The screening process for the highly anticipated procedure began late last year, the Cleveland Clinic says, with a group of transplant specialists, obstetricians and gynecologists, bioethicists, psychiatrists, nurses, and social workers examining the applications of numerous candidates who suffer from Uterine Factor Infertility (UFI), described as "an irreversible condition affecting 3 percent to 5 percent of women worldwide."
The transplant theoretically allows women who do not have a "competent" uterus, or one capable of carrying a fetus to term, to become pregnant and give birth, though it would have to be via in vitro fertilization. Prior to the procedure, the patient's eggs were surgically removed, fertilized with her husband's sperm, and subsequently frozen. In a year's time, she will be able to have the embryos transferred back to her new uterus with the hopes of bearing a child.
Related:
"Women who are coping with UFI have few existing options," Tommaso Falcone, chairman of the Department of Obstetrics-Gynecology at Cleveland Clinic, said last year, when the clinical trial was initially announced. "Although adoption and surrogacy provide opportunities for parenthood, both pose logistical challenges and may not be acceptable due to personal, cultural, or legal reasons."

Read more
Using stem cells, scientists just successfully grew a kidney organoid for the first time
Kidney waiting list transplants

Stem cell science has been a highly controversial topic over the years, but it may be well on its way to revolutionizing the high fatality rate expected for those on waitlists for vital organ donations. Stem cells have been particularly successful in this research because they can be scientifically bred into nearly any type of cell that occurs in the body. This key component means that crucial organs grown from stem cells would make urgent transplants viable without having to wait for donors that match a particular blood type or demographic bracket.

Since most humans can live with just one functioning kidney instead of two, transplants are often sourced from within family units or from personal relations when a patient is in urgent need. Unfortunately, that still doesn’t change the fact that, on average, 21 people die every day waiting for organ transplants because waitlists are too long or patient-donor matches can’t be found in time, according to the American Transplant Foundation.

Read more